Pfizer to test Xalkori lung cancer drug with Merck immunotherapy
Pfizer Inc said Tuesday it will test its Xalkori lung cancer drug with Merck & Co's experimental immunotherapy pembrolizumab, in hopes the combination will improve the outcomes for patients taking ...